Literature DB >> 25970943

Erythema multiforme--etiopathogenic, clinical and therapeutic aspects.

Anca Creţu, Andreea Dimitriu, D Brănişteanu, Daciana Elena Brinişteanu.   

Abstract

AIM: To present the epidemiological, etiopathogenic, clinical and therapeutic aspects in Erythema multiforme (EM).
MATERIAL AND METHODS: This is a 3-year retrospective study based on medical records of patients with EM admitted to the Dermatology Clinic. Forty patients were included in this study. The obtained data allowed the classification of patients according to their distribution by sex, age group, area of residence, etiology, clinical aspects, and type of administered treatment.
RESULTS: The prevalence of EM during the 3 study years was 0.4%. EM prevailed among the rural population, more frequently in women. The minimum age at which EM was diagnosed was 12 years and maximum age 78 years, with a peak incidence between 20-40 years old (37.5% cases). In 42.50% of the cases EM was drug-induced, and in 17.50% of cases it was caused by infection with herpes simplex virus (HSV). There were 18 cases of erythemotous-papular EM (45%), 14 cases of erythematous--vesiculobullous EM (35%) and 8 cases of recurrent EM (20%). All patients received treatment with antihistamines and nonspecific desensitizing agents. Systemic corticotherapy was used in 22 cases. Three patients received treatment with acyclovir.
CONCLUSIONS: Erythema multiforme is a rare skin condition, easily diagnosed based on its characteristic clinical appearance, but remains a challenge for the physician in terms of establishing its causal agent.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25970943

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  4 in total

1.  Autoimmune progesterone dermatitis manifesting as mucosal erythema multiforme in the setting of HIV infection.

Authors:  Kerrie M Grunnet; Kaitlyn S Powell; India A Miller; Loretta S Davis
Journal:  JAAD Case Rep       Date:  2016-12-24

2.  Drug-induced Rowell syndrome, a rare and difficult to manage disease: A case report.

Authors:  Daciana Elena Brănișteanu; Simona Laura Ianoşi; Andreea Dimitriu; Gabriela Stoleriu; Alexandru Oanţǎ; Daniel Constantin Brănișteanu
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

Review 3.  Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review).

Authors:  Irena Pintea; Carina Petricau; Dinu Dumitrascu; Adriana Muntean; Daniel Constantin Branisteanu; Daciana Elena Branisteanu; Diana Deleanu
Journal:  Exp Ther Med       Date:  2021-07-03       Impact factor: 2.447

4.  Rowell's syndrome: a rare but distinct entity in rheumatology.

Authors:  Atanu Chandra; Swarup Kanta Saha; Aritra Kumar Ray; Parthasarathi Karmakar
Journal:  BMJ Case Rep       Date:  2020-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.